RESULT_COUNT: 228,PAGE_SIZE: 10000,CURRENT_PAGE: 1,TOTAL_PAGES: 1,API_CALL_CREDITS: 1
TICKER,FIGI_TICKER,FIGI,TITLE,PUBLICATION_DATE,URL,SUMMARY
PRTA,PRTA:UW,BBG003PMQJT6,"Commit To Buy Prothena Corp At $40, Earn 10.2% Annualized Using Options",2017-10-17 16:52:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5BdGeLQMO-I/commit-to-buy-prothena-corp-at-40-earn-102-annualized-using-options-cm860789,Investors considering a purchase of Prothena Corp plc Symbol PRTA shares but cautious about paying the going market price of 61 58 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is the June
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Corp. Plc – Value Analysis (NASDAQ:PRTA) : October 16, 2017",2017-10-16 14:09:08 +0000,http://finance.yahoo.com/r/85084f8d-663c-3937-87d8-dd0c89f4b1fe/prothena-corp-plc-value-analysis-nasdaqprta-october-16-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Prothena Corp. Plc a score of 14. Our analysis is based on comparing Prothena Corp. Plc with the following peers – Alkermes Plc, Mallinckrodt Plc, Shire PLC Sponsored ADR, Alnylam Pharmaceuticals, Inc and Amarin Corporation Plc Sponsored ADR (ALKS-US, MNK-US, SHPG-US, ALNY-US and AMRN-US). Investment Outlook Prothena ... Read more
<b>(Read more...)</b>"
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Corp. Plc breached its 50 day moving average in a Bearish Manner : PRTA-US : October 13, 2017",2017-10-13 12:36:51 +0000,http://finance.yahoo.com/r/195e3d1e-b00c-3236-ad90-1ee514767350/prothena-corp-plc-breached-its-50-day-moving-average-in-a-bearish-manner-prta-us-october-13-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Prothena Corp. Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish ... Read more
<b>(Read more...)</b>"
PRTA,PRTA:UW,BBG003PMQJT6,Prothena's Psoriasis Candidate Disappoints in Phase I Study,2017-10-02 23:47:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dp1jKvYCHHM/prothenas-psoriasis-candidate-disappoints-in-phase-i-study-cm854267,Prothena Corporation plc PRTA announced results from a phase Ib multiple ascending dose MAD study of pipeline candidate PRX003 in psoriasis patients The primary objectives of the study were achieved However advancing PRX003 into mid stage clinical development required a well
PRTA,PRTA:UW,BBG003PMQJT6,Prothena&apos;s Psoriasis Candidate Disappoints in Phase I Study,2017-10-02 21:59:09 +0000,https://finance.yahoo.com/news/prothena-apos-psoriasis-candidate-disappoints-215909751.html?.tsrc=rss,"Prothena Corporation plc (PRTA) announced disappointing results from a phase Ib study of pipeline candidate, PRX003 in psoriasis patients."
PRTA,PRTA:UW,BBG003PMQJT6,Biotech Prothena shares fall after it scraps psoriasis trial,2017-09-29 15:52:47 +0000,http://finance.yahoo.com/r/9b42d687-ef4a-3b83-851a-9e7c9f214114/Story.aspx?guid=38230DD0-A887-4977-BC19-1DED2FF284D0&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Shares of biotech Prothena Corp. Plc slid 3.3% Friday, after the company said it was scrapping a psoriasis treatment after a trial failed to show the effects the company was seeking. Dublin-based Prothena ..."
PRTA,PRTA:UW,BBG003PMQJT6,Zogenix Soars After Epilepsy Drug Meets Primary Endpoint -Biotech Movers,2017-09-29 13:42:00 +0000,http://finance.yahoo.com/r/b2bfeadf-4bf0-3738-8e8a-131ae3ac539d/zogenix-soars-after-epilepsy-drug-meets-primary-endpoint.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The Emeryville, Calif.-based firm said its first Phase 3 study of ZX008 in Dravet syndrome achieved its primary endpoint. Dravet syndrome is a form of epilepsy."
PRTA,PRTA:UW,BBG003PMQJT6,Prothena Reports Results from Phase 1b Multiple Ascending Dose Study of PRX003 in Patients with Psoriasis,2017-09-28 20:05:00 +0000,https://finance.yahoo.com/news/prothena-reports-results-phase-1b-200500494.html?.tsrc=rss,"Data demonstrated consistent safety, tolerability and pharmacodynamic effects as previously reported from Phase 1 a single ascending dose study Observed clinical efficacy and reductions in markers of inflammation ..."
PRTA,PRTA:UW,BBG003PMQJT6,Stocks To Watch: Prothena Sees Relative Strength Rating Jump To 81,2017-09-27 14:56:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ucZemWcA9k4/stocks-to-watch-prothena-sees-relative-strength-rating-jump-to-81-cm851877,One important metric to look for in a stock is an 80 or higher Relative Strength Rating Prothena PRTA now clears that threshold with a jump from 78 to 81 Wednesday ibd display video id 449419 width 50 float left autostart true IBD s proprietary RS Rating
PRTA,PRTA:UW,BBG003PMQJT6,Stocks To Watch: Prothena Sees Relative Strength Rating Jump To 81,2017-09-27 07:00:00 +0000,http://finance.yahoo.com/r/52eed951-4180-3e1b-b986-18fb1cc73ec2/stocks-to-watch-prothena-sees-relative-strength-rating-jump-to-81?src=A00220&yptr=yahoo&.tsrc=rss,"Prothena shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 81."
PRTA,PRTA:UW,BBG003PMQJT6,Prothena Presents New Research Supporting Clinical Relevance of Cardiac Biomarker NT-proBNP in AL Amyloidosis,2017-09-18 12:00:00 +0000,https://finance.yahoo.com/news/prothena-presents-research-supporting-clinical-120000169.html?.tsrc=rss,Preclinical Research Demonstrating a Direct Relationship Between Misfolded Light Chain Toxicity and NT-proBNP Production Clinical Outcomes Research Showing a Correlation between NT-proBNP Response and ...
PRTA,PRTA:UW,BBG003PMQJT6,Stocks Flashing Renewed Technical Strength: Prothena,2017-09-18 07:00:00 +0000,http://finance.yahoo.com/r/fc5c7ae9-5806-3686-b19b-f6bd967ef643/stocks-flashing-renewed-technical-strength-prothena?src=A00220&yptr=yahoo&.tsrc=rss,A Relative Strength Rating upgrade for Prothena shows improving technical performance.
PRTA,PRTA:UW,BBG003PMQJT6,"ETFs with exposure to Prothena Corp. Plc : September 13, 2017",2017-09-13 23:55:04 +0000,http://finance.yahoo.com/r/d32ae04a-e51c-3c74-bf89-252e87af38ad/etfs-with-exposure-to-prothena-corp-plc-september-13-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Prothena Corp. Plc Here are 5 ETFs with the largest exposure to PRTA-US. Comparing the performance and risk of Prothena Corp. Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Corp. Plc :PRTA-US: Earnings Analysis: Q2, 2017 By the Numbers : September 11, 2017",2017-09-11 18:42:26 +0000,http://finance.yahoo.com/r/0402c7db-1f76-378a-845e-acae4cb7d016/prothena-corp-plc-prta-us-earnings-analysis-q2-2017-by-the-numbers-september-11-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Prothena Corp. Plc reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Prothena Corp. Plc – Alkermes Plc, Mallinckrodt Plc, Shire PLC Sponsored ADR, Alnylam Pharmaceuticals, Inc and Amarin Corporation Plc Sponsored ADR (ALKS-US, MNK-US, SHPG-US, ALNY-US and AMRN-US) that ... Read more
<b>(Read more...)</b>"
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Corp. Plc breached its 50 day moving average in a Bullish Manner : PRTA-US : September 1, 2017",2017-09-01 14:01:58 +0000,http://finance.yahoo.com/r/1d132dea-2064-3baf-aa4d-84d1cf319ad9/prothena-corp-plc-breached-its-50-day-moving-average-in-a-bullish-manner-prta-us-september-1-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Prothena Corp. Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish ... Read more
<b>(Read more...)</b>"
PRTA,PRTA:UW,BBG003PMQJT6,AstraZeneca and Takeda Ink Deal to Develop Parkinson's Drug,2017-08-30 17:51:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/P617KXLTQ_E/astrazeneca-and-takeda-ink-deal-to-develop-parkinsons-drug-cm839293,AstraZeneca PLC AZN and Takeda Pharmaceutical Company Limited a Japanese pharma company have entered into an agreement to jointly develop and commercialize preclinical candidate MEDI1341 In fact MEDI1341 is an alpha synuclein antibody being developed for the potential treatment
PRTA,PRTA:UW,BBG003PMQJT6,AstraZeneca and Takeda Ink Deal to Develop Parkinson&apos;s Drug,2017-08-30 15:44:03 +0000,https://finance.yahoo.com/news/astrazeneca-takeda-ink-deal-develop-154403444.html?.tsrc=rss,AstraZeneca (AZN) and Takeda Pharmaceutical Company entered into an agreement to jointly develop and commercialize MEDI1341 for the potential treatment of Parkinson&apos;s disease.
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Corp. Plc – Value Analysis (NASDAQ:PRTA) : August 23, 2017",2017-08-23 21:58:12 +0000,http://finance.yahoo.com/r/0c447776-0212-334b-80d3-bde0109d75f8/prothena-corp-plc-value-analysis-nasdaqprta-august-23-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Prothena Corp. Plc a score of 14. Our analysis is based on comparing Prothena Corp. Plc with the following peers – Alkermes Plc, Mallinckrodt Plc, Shire PLC Sponsored ADR, Alnylam Pharmaceuticals, Inc and Amarin Corporation Plc Sponsored ADR (ALKS-US, MNK-US, SHPG-US, ALNY-US and AMRN-US). Investment Outlook Prothena ... Read more
<b>(Read more...)</b>"
PRTA,PRTA:UW,BBG003PMQJT6,Prothena to Present New Research on Cardiac Biomarker NT-proBNP in AL Amyloidosis at HFSA Annual Meeting,2017-08-15 20:06:02 +0000,https://finance.yahoo.com/news/prothena-present-research-cardiac-biomarker-200602769.html?.tsrc=rss,Preclinical Research Demonstrating a Relationship Between Amyloid Light Chain Toxicity and NT-proBNP Production   Clinical Outcomes Research  Showing a Correlation between NT-proBNP and Health-related ...
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Corp. Plc breached its 50 day moving average in a Bearish Manner : PRTA-US : August 11, 2017",2017-08-11 14:12:16 +0000,http://finance.yahoo.com/r/3445a675-c659-3d85-86ce-dd5bdc81b10e/prothena-corp-plc-breached-its-50-day-moving-average-in-a-bearish-manner-prta-us-august-11-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Prothena Corp. Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish ... Read more
<b>(Read more...)</b>"
PRTA,PRTA:UW,BBG003PMQJT6,Prothena (PRTA) Q2 Loss Narrows as Roche Makes $30M Payment,2017-08-09 16:38:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0mQbpOr9XIs/prothena-prta-q2-loss-narrows-as-roche-makes-30m-payment-cm829515,Prothena Corporation plc PRTA reported a loss of 46 cents per share in the second quarter of 2017 narrower than the year ago loss of 1 18 and the Zacks Consensus Estimate loss of 89 cents Prothena Corporation PLC Price and EPS Surprise
PRTA,PRTA:UW,BBG003PMQJT6,Prothena (PRTA) Q2 Loss Narrows as Roche Makes $30M Payment,2017-08-09 14:55:02 +0000,https://finance.yahoo.com/news/prothena-prta-q2-loss-narrows-145502162.html?.tsrc=rss,Prothena Corporation plc (PRTA) reported a narrower-than-expected loss in the second quarter as the company received a milestone payment from Roche.
PRTA,PRTA:UW,BBG003PMQJT6,Prothena reports 2Q loss,2017-08-08 21:28:56 +0000,https://finance.yahoo.com/news/prothena-reports-2q-loss-212856036.html?.tsrc=rss,"On a per-share basis, the Dun Laoghaire, Ireland-based company said it had a loss of 46 cents. The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment ..."
PRTA,PRTA:UW,BBG003PMQJT6,Prothena Reports Second Quarter 2017 Financial Results and Provides R&D Update,2017-08-08 20:07:00 +0000,https://finance.yahoo.com/news/prothena-reports-second-quarter-2017-200700987.html?.tsrc=rss,"Net cash used in operating and investing activities was $36.3 million in the second quarter and $76.5 million for the first six months of 2017; quarter-end cash and restricted cash position of $475.8 million, ..."
PRTA,PRTA:UW,BBG003PMQJT6,Should You Buy Prothena Corporation PLC (PRTA) Ahead of Earnings?,2017-08-07 14:42:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/524O2PIV2jg/should-you-buy-prothena-corporation-plc-prta-ahead-of-earnings-cm828028,Investors are always looking for stocks that are poised to beat at earnings season and Prothena Corporation PLC PRTA 160 may be one such company The firm has earnings coming up pretty soon and events are shaping up quite nicely for their report That is because Prothena Corpis
PRTA,PRTA:UW,BBG003PMQJT6,Should You Buy Prothena Corporation PLC (PRTA) Ahead of Earnings?,2017-08-07 12:35:12 +0000,https://finance.yahoo.com/news/buy-prothena-corporation-plc-prta-123512998.html?.tsrc=rss,"Given that Prothena Corporation PLC (PRTA) has a Zacks Rank #3 (Hold) and an ESP in positive territory, investors might want to consider this stock ahead of earnings."
PRTA,PRTA:UW,BBG003PMQJT6,Prothena to Report Second Quarter 2017 Financial Results on August 8,2017-08-01 20:06:02 +0000,https://finance.yahoo.com/news/prothena-report-second-quarter-2017-200602970.html?.tsrc=rss,"DUBLIN, Ireland, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel ..."
PRTA,PRTA:UW,BBG003PMQJT6,Can Prothena (PRTA) Deliver a Beat this Earnings Season?,2017-07-28 13:57:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H_YAN5bPC7k/can-prothena-prta-deliver-a-beat-this-earnings-season-cm823114,Prothena Corporation plc PRTA is expected to report second quarter 2017 results on Aug 1 Last quarter the company reported a narrower than expected loss resulting in a positive earnings surprise of 25 0 160 Notably Prothena s track record has been dismal so far The company reported
PRTA,PRTA:UW,BBG003PMQJT6,Can Prothena (PRTA) Deliver a Beat this Earnings Season?,2017-07-28 13:17:01 +0000,https://finance.yahoo.com/news/prothena-prta-deliver-beat-earnings-131701756.html?.tsrc=rss,Prothena Corporation plc (PRTA) is expected to report second-quarter results next week and we expect investor focus on pipeline updates.
PRTA,PRTA:UW,BBG003PMQJT6,"Commit To Purchase Prothena Corp At $45, Earn 15% Annualized Using Options",2017-07-06 16:44:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dH9TyA4pZ4Y/commit-to-purchase-prothena-corp-at-45-earn-15-annualized-using-options-cm812472,Investors considering a purchase of Prothena Corp plc Symbol PRTA shares but cautious about paying the going market price of 57 61 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is the
PRTA,PRTA:UW,BBG003PMQJT6,"ARRY Working Its Way, Be All Ears For Auris, BGNE Inks Deal With CELG",2017-07-06 04:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/S1i7ltsXB9E/arry-working-its-way-be-all-ears-for-auris-bgne-inks-deal-with-celg-20170706-00114,"ARRY Working Its Way, Be All Ears For Auris, BGNE Inks Deal With CELG"
PRTA,PRTA:UW,BBG003PMQJT6,Prothena Announces Initiation of Phase 2 PASADENA Study of PRX002/RG7935 in Patients with Early Parkinson's Disease,2017-07-05 20:06:01 +0000,https://finance.yahoo.com/news/prothena-announces-initiation-phase-2-200601061.html?.tsrc=rss,First potentially disease-modifying anti-alpha-synuclein antibody to be evaluated for efficacy in patients with Parkinson`s disease Prothena to receive $30 million milestone payment under collaboration ...
PRTA,PRTA:UW,BBG003PMQJT6,Muddy Waters Shorts Prothena On Doubts Of Drug Candidate's Efficacy,2017-06-29 19:10:02 +0000,https://finance.yahoo.com/news/muddy-waters-shorts-prothena-doubts-191002462.html?.tsrc=rss,Short-seller Muddy Waters Research has a new target for its cynical trade strategy. The firm’s Carson Block announced a short position in Prothena Corporation PLC (NASDAQ: PRTA ) Thursday on Bloomberg ...
PRTA,PRTA:UW,BBG003PMQJT6,Feared short seller Carson Block&apos;s next target is this biotech stock,2017-06-29 18:01:36 +0000,https://finance.yahoo.com/news/feared-short-seller-carson-block-180136375.html?.tsrc=rss,Muddy Waters&apos; Carson Block posted a bearish report on Prothena.
PRTA,PRTA:UW,BBG003PMQJT6,Feared short seller Carson Block's next target is this biotech stock,2017-06-29 18:01:36 +0000,http://finance.yahoo.com/r/1eb96f97-83f5-33e0-aba4-0ec3adcfd390/104559398?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104559398&yptr=yahoo&.tsrc=rss,Muddy Waters' Carson Block posted a bearish report on Prothena.
PRTA,PRTA:UW,BBG003PMQJT6,Carson Block Shorts Prothena on Drug Questions,2017-06-29 15:45:04 +0000,https://finance.yahoo.com/video/carson-block-shorts-prothena-drug-154504257.html?.tsrc=rss,"Jun.29 -- Carson Block, chief investment officer and founder at Muddy Waters Capital, explains why he shorted the stock of Prothena Corp. Plc. He speaks with Bloomberg's Julia Chatterley on &quot;Bloomberg Markets.&quot;"
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Corp. Plc breached its 50 day moving average in a Bearish Manner : PRTA-US : June 28, 2017",2017-06-28 13:06:05 +0000,http://finance.yahoo.com/r/eb6992d8-f0d8-3ceb-97b2-497914fb0b84/prothena-corp-plc-breached-its-50-day-moving-average-in-a-bearish-manner-prta-us-june-28-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Prothena Corp. Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish ... Read more
<b>(Read more...)</b>"
PRTA,PRTA:UW,BBG003PMQJT6,PRTA Crosses Below Key Moving Average Level,2017-06-27 21:50:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AnnD8cfV_08/prta-crosses-below-key-moving-average-level-cm809075,In trading on Tuesday shares of Prothena Corp plc Symbol PRTA crossed below their 200 day moving average of 54 06 changing hands as low as 52 89 per share Prothena Corp plc shares are currently trading off about 7 8 on the day The chart below shows the one year performance of PRTA
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Corp. Plc – Value Analysis (NASDAQ:PRTA) : June 15, 2017",2017-06-15 20:28:45 +0000,http://finance.yahoo.com/r/f98b51f4-4078-37e7-9cb6-188f43f3d0e7/prothena-corp-plc-value-analysis-nasdaqprta-june-15-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Prothena Corp. Plc a score of 14. Our analysis is based on comparing Prothena Corp. Plc with the following peers – Alkermes Plc, Mallinckrodt Plc, Shire PLC Sponsored ADR, Alnylam Pharmaceuticals, Inc and Amarin Corporation Plc Sponsored ADR (ALKS-US, MNK-US, SHPG-US, ALNY-US and AMRN-US). Investment Outlook Prothena ... Read more
<b>(Read more...)</b>"
PRTA,PRTA:UW,BBG003PMQJT6,"ETFs with exposure to Prothena Corp. Plc : June 15, 2017",2017-06-15 19:03:19 +0000,http://finance.yahoo.com/r/7b2c3ef7-94ce-3a19-8180-ec60e32aaba9/etfs-with-exposure-to-prothena-corp-plc-june-15-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Prothena Corp. Plc Here are 5 ETFs with the largest exposure to PRTA-US. Comparing the performance and risk of Prothena Corp. Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Corp. Plc breached its 50 day moving average in a Bullish Manner : PRTA-US : June 14, 2017",2017-06-14 12:21:24 +0000,http://finance.yahoo.com/r/b6780512-b6eb-3878-a165-1c10f9133e75/prothena-corp-plc-breached-its-50-day-moving-average-in-a-bullish-manner-prta-us-june-14-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Prothena Corp. Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish ... Read more
<b>(Read more...)</b>"
PRTA,PRTA:UW,BBG003PMQJT6,Prothena (PRTA) Down 5.8% Since Earnings Report: Can It Rebound?,2017-06-14 08:27:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CAZQM-fy4ak/prothena-prta-down-58-since-earnings-report-can-it-rebound-cm803052,It has been about a month since the last earnings report for Prothena Corporation PLC PRTA Shares have lost about 5 8 in that time frame underperforming the market Will the recent negative trend continue leading up to the stock s next earnings release or is it due for a breakout Before
PRTA,PRTA:UW,BBG003PMQJT6,Prothena (PRTA) Down 5.8% Since Earnings Report: Can It Rebound?,2017-06-14 05:56:05 +0000,https://finance.yahoo.com/news/prothena-prta-down-5-8-055605250.html?.tsrc=rss,Prothena (PRTA) reported earnings 30 days ago. What&apos;s next for the stock? We take a look at earnings estimates for some clues.
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Announces Appointment of Wagner Zago, PhD as Chief Scientific Officer",2017-06-12 13:01:01 +0000,https://finance.yahoo.com/news/prothena-announces-appointment-wagner-zago-130101640.html?.tsrc=rss,"DUBLIN, Ireland, June 12, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel ..."
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Corp. Plc breached its 50 day moving average in a Bearish Manner : PRTA-US : May 29, 2017",2017-05-29 12:22:18 +0000,http://finance.yahoo.com/r/205d584a-ea78-3f62-bc1e-0903591a50db/prothena-corp-plc-breached-its-50-day-moving-average-in-a-bearish-manner-prta-us-may-29-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Prothena Corp. Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more
<b>(Read more...)</b>"
PRTA,PRTA:UW,BBG003PMQJT6,PRTA Makes Notable Cross Below Critical Moving Average,2017-05-26 17:33:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/B-W08NDZWzo/prta-makes-notable-cross-below-critical-moving-average-cm795420,In trading on Friday shares of Prothena Corp plc Symbol PRTA crossed below their 200 day moving average of 54 16 changing hands as low as 52 43 per share Prothena Corp plc shares are currently trading down about 3 5 on the day The chart below shows the one year performance of PRTA
PRTA,PRTA:UW,BBG003PMQJT6,"Woodford Investment Management LLP Buys Gilead Sciences Inc, Bioverativ Inc, Biogen Inc, Sells ...",2017-05-23 18:11:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/garelQectKM/woodford-investment-management-llp-buys-gilead-sciences-inc-bioverativ-inc-biogen-inc-sells-cm793495,Woodford Investment Management LLP Added Positions GILD PRTA BIVV BIIB TBPH Reduced Positions ABBV Sold Out NWBO Added Positions GILD PRTA BIVV BIIB TBPH Added Positions GILD PRTA BIVV BIIB
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Announces Appointment of Sarah Noonberg, MD, PhD as Chief Medical Officer",2017-05-16 20:06:02 +0000,https://finance.yahoo.com/news/prothena-announces-appointment-sarah-noonberg-200602294.html?.tsrc=rss,"DUBLIN, Ireland, May 16, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel ..."
PRTA,PRTA:UW,BBG003PMQJT6,"ETFs with exposure to Prothena Corp. Plc : May 15, 2017",2017-05-15 20:24:32 +0000,http://finance.yahoo.com/r/c04575a5-3869-33a6-890d-6b113e72d65b/etfs-with-exposure-to-prothena-corp-plc-may-15-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Prothena Corp. Plc Here are 5 ETFs with the largest exposure to PRTA-US. Comparing the performance and risk of Prothena Corp. Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Corp. Plc breached its 50 day moving average in a Bullish Manner : PRTA-US : May 15, 2017",2017-05-15 12:19:47 +0000,http://finance.yahoo.com/r/dc2ce41b-512a-30fe-96d3-d0d305e3d33c/prothena-corp-plc-breached-its-50-day-moving-average-in-a-bullish-manner-prta-us-may-15-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Prothena Corp. Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving ... Read more
<b>(Read more...)</b>"
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Corp. Plc :PRTA-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017",2017-05-12 14:55:44 +0000,http://finance.yahoo.com/r/94b9b740-fadf-3668-960d-9d31e4114e20/prothena-corp-plc-prta-us-earnings-analysis-q1-2017-by-the-numbers-may-12-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Prothena Corp. Plc reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Prothena Corp. Plc – Alkermes Plc, Mallinckrodt Plc, Shire PLC Sponsored ADR, Alnylam Pharmaceuticals, Inc and Amarin Corporation Plc Sponsored ADR (ALKS-US, MNK-US, SHPG-US, ALNY-US and AMRN-US) that ... Read more
<b>(Read more...)</b>"
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena (PRTA) Q1 Loss Narrower than Expected, Updates View",2017-05-10 20:03:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ns-6sdtfgYk/prothena-prta-q1-loss-narrower-than-expected-updates-view-cm787444,Prothena Corporation plc PRTA reported a loss of 99 cents per share in the first quarter of 2017 wider than the year ago loss of 81 cents but narrower than the Zacks Consensus Estimate of 1 32 160 Moreover quarterly revenues were 0 3 million roughly flat from the year ago quarter and
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena (PRTA) Q1 Loss Narrower than Expected, Updates View",2017-05-10 17:52:05 +0000,http://finance.yahoo.com/news/prothena-prta-q1-loss-narrower-175205075.html?.tsrc=rss,"Prothena Corporation plc (PRTA) reported a loss of 99 cents per share in the first quarter of 2017, wider than the year-ago loss of 81 cents."
PRTA,PRTA:UW,BBG003PMQJT6,Prothena reports 1Q loss,2017-05-09 21:52:25 +0000,http://finance.yahoo.com/news/prothena-reports-1q-loss-215225533.html?.tsrc=rss,"On a per-share basis, the Dublin-based company said it had a loss of 99 cents. The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research ..."
PRTA,PRTA:UW,BBG003PMQJT6,Prothena Reports First Quarter 2017 Financial Results and Provides R&D Update,2017-05-09 20:06:01 +0000,http://finance.yahoo.com/news/prothena-reports-first-quarter-2017-200601186.html?.tsrc=rss,"Net cash used in operating and investing activities was $40.2 million in the first quarter; quarter-end cash and restricted cash position of $510.6 million, including net proceeds of $150.3 million raised ..."
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Corp. Plc breached its 50 day moving average in a Bearish Manner : PRTA-US : May 4, 2017",2017-05-04 12:54:40 +0000,http://finance.yahoo.com/r/19472503-9dd8-37db-b8ce-e0d22c6f8490/prothena-corp-plc-breached-its-50-day-moving-average-in-a-bearish-manner-prta-us-may-4-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Prothena Corp. Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more
<b>(Read more...)</b>"
PRTA,PRTA:UW,BBG003PMQJT6,Prothena to Report First Quarter 2017 Financial Results on May 9,2017-05-02 20:05:00 +0000,http://finance.yahoo.com/news/prothena-report-first-quarter-2017-200500210.html?.tsrc=rss,"DUBLIN, Ireland, May 02, 2017-- Prothena Corporation plc, a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapies, will ..."
PRTA,PRTA:UW,BBG003PMQJT6,PRTA Makes Notable Cross Below Critical Moving Average,2017-05-02 17:29:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kG7sjV0Cyao/prta-makes-notable-cross-below-critical-moving-average-cm782860,In trading on Tuesday shares of Prothena Corp plc Symbol PRTA crossed below their 200 day moving average of 54 06 changing hands as low as 53 62 per share Prothena Corp plc shares are currently trading down about 2 2 on the day The chart below shows the one year performance of
PRTA,PRTA:UW,BBG003PMQJT6,What to Expect from Prothena (PRTA) This Earnings Season?,2017-04-26 21:13:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uXtkTkX9oEI/what-to-expect-from-prothena-prta-this-earnings-season-cm779926,Prothena Corporation plc PRTA is expected to report first quarter 2017 results early next month Last quarter the company recorded a negative earnings surprise of 13 71 In fact Prothena s track record has been dismal so far The company reported a wider than expected loss in all the
PRTA,PRTA:UW,BBG003PMQJT6,What to Expect from Prothena (PRTA) This Earnings Season?,2017-04-26 20:19:08 +0000,http://finance.yahoo.com/news/expect-prothena-prta-earnings-season-201908476.html?.tsrc=rss,Prothena Corporation plc (PRTA) is expected to report first-quarter 2017 results early next month.
PRTA,PRTA:UW,BBG003PMQJT6,Prothena to Participate in the Deutsche Bank 42nd Annual Health Care Conference,2017-04-26 20:06:03 +0000,http://finance.yahoo.com/news/prothena-participate-deutsche-bank-42nd-200603277.html?.tsrc=rss,"DUBLIN, Ireland, April 26, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel ..."
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Corp. Plc – Value Analysis (NASDAQ:PRTA) : April 24, 2017",2017-04-24 19:46:13 +0000,http://finance.yahoo.com/r/3784af4f-fa28-3a37-a32c-c8fccc3530ad/prothena-corp-plc-value-analysis-nasdaqprta-april-24-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Prothena Corp. Plc a score of 14. Our analysis is based on comparing Prothena Corp. Plc with the following peers – Alkermes Plc, Mallinckrodt Plc, Shire PLC Sponsored ADR, Alnylam Pharmaceuticals, Inc and Amarin Corporation Plc Sponsored ADR (ALKS-US, MNK-US, SHPG-US, ALNY-US and AMRN-US). Investment Outlook Prothena ... Read more
<b>(Read more...)</b>"
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Corp. Plc breached its 50 day moving average in a Bullish Manner : PRTA-US : April 21, 2017",2017-04-21 12:48:12 +0000,http://finance.yahoo.com/r/08d129ba-9e25-3dcf-a9c5-c2df5210a1d6/prothena-corp-plc-breached-its-50-day-moving-average-in-a-bullish-manner-prta-us-april-21-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Prothena Corp. Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving ... Read more
<b>(Read more...)</b>"
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Corp. Plc breached its 50 day moving average in a Bearish Manner : PRTA-US : April 6, 2017",2017-04-06 12:29:22 +0000,http://finance.yahoo.com/r/e59a1745-2ebd-3515-bff3-c8d8871903fd/prothena-corp-plc-breached-its-50-day-moving-average-in-a-bearish-manner-prta-us-april-6-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Prothena Corp. Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more
<b>(Read more...)</b>"
PRTA,PRTA:UW,BBG003PMQJT6,3:12 am Prothena presents results from Phase 1b Study of PRX002/RG7935 that demonstrate robust antibody CNS penetration and significant reduction of free serum alpha-synuclein,2017-04-03 07:12:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#prta,3:12 am Prothena presents results from Phase 1b Study of PRX002/RG7935 that demonstrate robust antibody CNS penetration and significant reduction of free serum alpha-synuclein
PRTA,PRTA:UW,BBG003PMQJT6,Prothena Corporation plc : Press Release,2017-04-02 12:01:02 +0000,http://finance.yahoo.com/news/prothena-corporation-plc-press-release-120102354.html,[GlobeNewswire] - Clinical Results Presented from Prothena`s Phase 1b Study of PRX002/RG7935 Demonstrating Robust Antibody CNS Penetration and Significant Reduction of Free Serum Alpha-synuclein in Patients with Parkinson`s ...
PRTA,PRTA:UW,BBG003PMQJT6,Prothena Corporation plc : Press Release,2017-04-02 12:01:02 +0000,http://finance.yahoo.com/news/prothena-corporation-plc-press-release-120102354.html?.tsrc=rss,Clinical Results Presented from Prothena`s Phase 1b Study of PRX002/RG7935 Demonstrating Robust Antibody CNS Penetration and Significant Reduction of Free Serum Alpha-synuclein in Patients with Parkinson`s ...
PRTA,PRTA:UW,BBG003PMQJT6,Clinical Results Presented from Prothena’s Phase 1b Study of PRX002/RG7935 Demonstrating Robust Antibody CNS Penetration and Significant Reduction of Free Serum Alpha-synuclein in Patients with Parkinson’s Disease,2017-04-02 12:00:00 +0000,http://finance.yahoo.com/news/clinical-results-presented-prothena-phase-120000648.html,"[GlobeNewswire] - All dose levels of PRX002/RG7935 found to have an acceptable safety and tolerability profile, meeting the primary objective of this study Robust central nervous system penetration demonstrated by a dose-dependent ..."
PRTA,PRTA:UW,BBG003PMQJT6,Clinical Results Presented from Prothena’s Phase 1b Study of PRX002/RG7935 Demonstrating Robust Antibody CNS Penetration and Significant Reduction of Free Serum Alpha-synuclein in Patients with Parkinson’s Disease,2017-04-02 12:00:00 +0000,http://finance.yahoo.com/news/clinical-results-presented-prothena-phase-120000648.html?.tsrc=rss,"All dose levels of PRX002/RG7935 found to have an acceptable safety and tolerability profile, meeting the primary objective of this study Robust central nervous system penetration demonstrated by a dose-dependent ..."
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Corp. Plc breached its 50 day moving average in a Bullish Manner : PRTA-US : March 27, 2017",2017-03-27 12:06:55 +0000,http://www.capitalcube.com/blog/index.php/prothena-corp-plc-breached-its-50-day-moving-average-in-a-bullish-manner-prta-us-march-27-2017/,"Prothena Corp. Plc breached its 50 day moving average in a Bullish Manner : PRTA-US : March 27, 2017"
PRTA,PRTA:UW,BBG003PMQJT6,Don't Let Offerings Blindside Your Thesis,2017-03-19 17:51:48 +0000,http://finance.yahoo.com/news/dont-let-offerings-blindside-thesis-175148225.html?.tsrc=rss,"Where offerings are concerned, IPOs take the cake, given the hype surrounding the events. Their lesser brethren, secondary offerings, do not attract as significant attention, often passed off as routine ..."
PRTA,PRTA:UW,BBG003PMQJT6,Don't Let Offerings Blindside Your Thesis,2017-03-19 17:51:48 +0000,http://finance.yahoo.com/news/dont-let-offerings-blindside-thesis-175148225.html,Don't Let Offerings Blindside Your Thesis
PRTA,PRTA:UW,BBG003PMQJT6,Why Is Prothena (PRTA) Up 4.5% Since the Last Earnings Report?,2017-03-17 14:09:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4n0lINpipxk/why-is-prothena-prta-up-45-since-the-last-earnings-report-cm762104,It has been about a month since the last earnings report for Prothena Corporation PLC PRTA Shares have added about 4 5 in that time frame outperforming the market Will the recent positive trend continue leading up to the stock s next earnings release or is it due for a pullback Before
PRTA,PRTA:UW,BBG003PMQJT6,Why Is Prothena (PRTA) Up 4.5% Since the Last Earnings Report?,2017-03-17 11:45:11 +0000,http://finance.yahoo.com/news/why-prothena-prta-4-5-114511958.html?.tsrc=rss,Prothena (PRTA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
PRTA,PRTA:UW,BBG003PMQJT6,Why Is Prothena (PRTA) Up 4.5% Since the Last Earnings Report?,2017-03-17 11:45:11 +0000,http://finance.yahoo.com/news/why-prothena-prta-4-5-114511958.html,Why Is Prothena (PRTA) Up 4.5% Since the Last Earnings Report?
PRTA,PRTA:UW,BBG003PMQJT6,Results for Prothena's Phase 1b Multiple Ascending Dose Study of PRX002...,2017-03-09 21:06:02 +0000,http://finance.yahoo.com/news/results-prothenas-phase-1b-multiple-210602587.html?.tsrc=rss,Results for Prothena`s Phase 1b Multiple Ascending Dose Study of PRX002/RG7935 in Patients with Parkinson`s Disease to be Presented at the 13th International Conference on Alzheimer`s and Parkinson`s Diseases ...
PRTA,PRTA:UW,BBG003PMQJT6,Results for Prothena's Phase 1b Multiple Ascending Dose Study of PRX002...,2017-03-09 21:06:02 +0000,http://finance.yahoo.com/news/results-prothenas-phase-1b-multiple-210602587.html,[GlobeNewswire] - Results for Prothena`s Phase 1b Multiple Ascending Dose Study of PRX002/RG7935 in Patients with Parkinson`s Disease to be Presented at the 13th International Conference on Alzheimer`s and Parkinson`s Diseases ...
PRTA,PRTA:UW,BBG003PMQJT6,Results for Prothena’s Phase 1b Multiple Ascending Dose Study of PRX002/RG7935 in Patients with Parkinson’s Disease to be Presented at the 13th​ International Conference on Alzheimer's and Parkinson's Diseases,2017-03-09 21:05:00 +0000,http://finance.yahoo.com/news/results-prothena-phase-1b-multiple-210500562.html,"[GlobeNewswire] - Investor webcast planned for April 2, 2017 at 9:00 AM EDT to discuss Phase 1 b study results Prothena and Roche to co-host symposium on alpha-synuclein pathology and non-motor manifestations in Parkinson’ ..."
PRTA,PRTA:UW,BBG003PMQJT6,Results for Prothena’s Phase 1b Multiple Ascending Dose Study of PRX002/RG7935 in Patients with Parkinson’s Disease to be Presented at the 13th​ International Conference on Alzheimer's and Parkinson's Diseases,2017-03-09 21:05:00 +0000,http://finance.yahoo.com/news/results-prothena-phase-1b-multiple-210500562.html?.tsrc=rss,"Investor webcast planned for April 2, 2017 at 9:00 AM EDT to discuss Phase 1 b study results Prothena and Roche to co-host symposium on alpha-synuclein pathology and non-motor manifestations in Parkinson’ ..."
PRTA,PRTA:UW,BBG003PMQJT6,"PROTHENA CORP PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2017-03-08 21:07:53 +0000,http://biz.yahoo.com/e/170308/prta8-k.html,"PROTHENA CORP PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
PRTA,PRTA:UW,BBG003PMQJT6,"Notable Friday Option Activity: CCL, PRTA, CELG",2017-03-03 22:12:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9UGSLgTDljQ/notable-friday-option-activity-ccl-prta-celg-cm756181,Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Carnival Corp Symbol CCL where a total of 11 707 contracts have traded so far representing approximately 1 2 million underlying shares That amounts to about 43 4 of CCL s
PRTA,PRTA:UW,BBG003PMQJT6,Prothena Raises $155.3M to Bring Anti-Organ Failure Drug to Market,2017-03-03 19:00:00 +0000,http://finance.yahoo.com/r/6c1592f0-8241-3472-b1d3-c512f445e050/prothena-raises-155-3m-to-bring-anti-organ-failure-drug-to-market.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The biotech company plans to commercialize its treatment for AL amyloidosis, a disease that causes protein to build up in the blood."
PRTA,PRTA:UW,BBG003PMQJT6,Prothena Raises $155.3M to Bring Anti-Organ Failure Drug to Market,2017-03-03 19:00:00 +0000,https://www.thestreet.com/story/14026062/1/prothena-raises-155-3m-to-bring-anti-organ-failure-drug-to-market.html?puc=yahoo&cm_ven=YAHOO,Prothena Raises $155.3M to Bring Anti-Organ Failure Drug to Market
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Announces Pricing of Public Offering of 2,700,000 Ordinary Shares",2017-03-03 13:31:01 +0000,http://finance.yahoo.com/news/prothena-announces-pricing-public-offering-133101383.html?.tsrc=rss,"DUBLIN, Ireland, March 03, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel ..."
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Announces Pricing of Public Offering of 2,700,000 Ordinary Shares",2017-03-03 13:31:01 +0000,http://finance.yahoo.com/news/prothena-announces-pricing-public-offering-133101383.html,"[GlobeNewswire] - DUBLIN, Ireland, March 03, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel ..."
PRTA,PRTA:UW,BBG003PMQJT6,Prothena Corporation plc : Prothena Announces Public Offering of Ordinary Shares,2017-03-02 21:02:01 +0000,http://finance.yahoo.com/news/prothena-corporation-plc-prothena-announces-210201865.html,"[GlobeNewswire] - DUBLIN, Ireland, March 02, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel ..."
PRTA,PRTA:UW,BBG003PMQJT6,Prothena Corporation plc : Prothena Announces Public Offering of Ordinary Shares,2017-03-02 21:02:01 +0000,http://finance.yahoo.com/news/prothena-corporation-plc-prothena-announces-210201865.html?.tsrc=rss,"DUBLIN, Ireland, March 02, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel ..."
PRTA,PRTA:UW,BBG003PMQJT6,Prothena Announces Public Offering of Ordinary Shares,2017-03-02 21:01:00 +0000,http://finance.yahoo.com/news/prothena-announces-public-offering-ordinary-210100976.html,"[GlobeNewswire] - DUBLIN, Ireland, March 02, 2017-- Prothena Corporation plc, a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapies, today ..."
PRTA,PRTA:UW,BBG003PMQJT6,Prothena Announces Public Offering of Ordinary Shares,2017-03-02 21:01:00 +0000,http://finance.yahoo.com/news/prothena-announces-public-offering-ordinary-210100976.html?.tsrc=rss,"DUBLIN, Ireland, March 02, 2017-- Prothena Corporation plc, a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapies, today ..."
PRTA,PRTA:UW,BBG003PMQJT6,PROTHENA CORP PLC Financials,2017-03-02 18:04:18 +0000,http://finance.yahoo.com/q/is?s=prta,PROTHENA CORP PLC Financials
PRTA,PRTA:UW,BBG003PMQJT6,Coverage initiated on Prothena by Instinet,2017-03-02 13:43:22 +0000,http://finance.yahoo.com/q/ud?s=PRTA,Coverage initiated on Prothena by Instinet
PRTA,PRTA:UW,BBG003PMQJT6,"PROTHENA CORP PLC Files SEC form 10-K, Annual Report",2017-02-27 11:11:39 +0000,http://biz.yahoo.com/e/170227/prta10-k.html,"PROTHENA CORP PLC Files SEC form 10-K, Annual Report"
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Corp. Plc :PRTA-US: Earnings Analysis: 2016 By the Numbers : February 17, 2017",2017-02-17 17:30:52 +0000,http://www.capitalcube.com/blog/index.php/prothena-corp-plc-prta-us-earnings-analysis-2016-by-the-numbers-february-17-2017/,"Prothena Corp. Plc :PRTA-US: Earnings Analysis: 2016 By the Numbers : February 17, 2017"
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Corp. Plc :PRTA-US: Earnings Analysis: 2016 By the Numbers : February 17, 2017",2017-02-17 17:30:52 +0000,http://finance.yahoo.com/r/a1b03bd7-18a6-3cae-a27a-7d73bcb8ec9f/prothena-corp-plc-prta-us-earnings-analysis-2016-by-the-numbers-february-17-2017?yptr=yahoo&.tsrc=rss,"Categories:   Yahoo Finance Get free summary analysis Prothena Corp. Plc reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Prothena Corp. Plc – Alkermes Plc, Mallinckrodt Plc and Alnylam Pharmaceuticals, Inc (ALKS-US, MNK-US and ALNY-US) that have also reported for this period. Highlights Narrowing of operating margins ... Read more    
<b>(Read more...)</b>"
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Corp. Plc :PRTA-US: Earnings Analysis: Q4, 2016 By the Numbers : February 16, 2017",2017-02-16 15:48:10 +0000,http://www.capitalcube.com/blog/index.php/prothena-corp-plc-prta-us-earnings-analysis-q4-2016-by-the-numbers-february-16-2017/,"Prothena Corp. Plc :PRTA-US: Earnings Analysis: Q4, 2016 By the Numbers : February 16, 2017"
PRTA,PRTA:UW,BBG003PMQJT6,Prothena (PRTA) Reports Wider-than-Expected Loss in Q4,2017-02-15 21:55:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5CuzB-tCsHI/prothena-prta-reports-wider-than-expected-loss-in-q4-cm748541,Prothena Corporation plc PRTA reported a loss of 1 41 per share in the fourth quarter of 2016 wider than both the Zacks Consensus Estimate of a loss of 1 24 and the year ago loss of 76 cents Moreover quarterly revenues came in at 0 2 million down 44 3 primarily due to lower
PRTA,PRTA:UW,BBG003PMQJT6,Prothena (PRTA) Reports Wider-than-Expected Loss in Q4,2017-02-15 19:36:07 +0000,http://finance.yahoo.com/news/prothena-prta-reports-wider-expected-193607656.html,Prothena (PRTA) Reports Wider-than-Expected Loss in Q4
PRTA,PRTA:UW,BBG003PMQJT6,Prothena (PRTA) Reports Wider-than-Expected Loss in Q4,2017-02-15 19:36:07 +0000,http://finance.yahoo.com/news/prothena-prta-reports-wider-expected-193607656.html?.tsrc=rss,Prothena's wider-than-expected loss in the fourth quarter was disappointing.
PRTA,PRTA:UW,BBG003PMQJT6,Edited Transcript of PRTA earnings conference call or presentation 14-Feb-17 9:30pm GMT,2017-02-15 06:11:56 +0000,http://finance.yahoo.com/news/edited-transcript-prta-earnings-conference-061156009.html,Edited Transcript of PRTA earnings conference call or presentation 14-Feb-17 9:30pm GMT
PRTA,PRTA:UW,BBG003PMQJT6,Edited Transcript of PRTA earnings conference call or presentation 14-Feb-17 9:30pm GMT,2017-02-15 06:11:56 +0000,http://finance.yahoo.com/news/edited-transcript-prta-earnings-conference-061156009.html?.tsrc=rss,Q4 2016 Prothena Corporation PLC Earnings Call
PRTA,PRTA:UW,BBG003PMQJT6,"AXSM On Fast Track, MRK Halts Alzheimer's Drug Study, HOLX Snaps Up CYNO",2017-02-15 04:46:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jODu9Rfmmso/axsm-on-fast-track-mrk-halts-alzheimers-drug-study-holx-snaps-up-cyno-20170215-00195,"AXSM On Fast Track, MRK Halts Alzheimer's Drug Study, HOLX Snaps Up CYNO"
PRTA,PRTA:UW,BBG003PMQJT6,Prothena reports 4Q loss,2017-02-14 22:01:39 +0000,http://finance.yahoo.com/news/prothena-reports-4q-loss-220139690.html?.tsrc=rss,The Dublin-based company said it had a loss of $1.41 per share. The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of ...
PRTA,PRTA:UW,BBG003PMQJT6,Prothena reports 4Q loss,2017-02-14 22:01:39 +0000,http://sg.finance.yahoo.com/news/prothena-reports-4q-loss-220139426.html,Prothena reports 4Q loss
PRTA,PRTA:UW,BBG003PMQJT6,"PROTHENA CORP PLC Files SEC form 8-K, Results of Operations and Financial Condition",2017-02-14 21:27:25 +0000,http://biz.yahoo.com/e/170214/prta8-k.html,"PROTHENA CORP PLC Files SEC form 8-K, Results of Operations and Financial Condition"
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Reports Fourth Quarter and Full Year 2016 Financial Results, and Provides Financial Guidance and R&D Update",2017-02-14 21:06:02 +0000,http://finance.yahoo.com/news/prothena-reports-fourth-quarter-full-210602105.html?.tsrc=rss,Net cash used in operating and investing activities was $41.1 million in the fourth quarter and $133.9 million for the full year 2016; year-end cash and restricted cash position of $391 million supports ...
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Reports Fourth Quarter and Full Year 2016 Financial Results, and Provides Financial Guidance and R&D Update",2017-02-14 21:06:02 +0000,http://finance.yahoo.com/news/prothena-reports-fourth-quarter-full-210602105.html,[GlobeNewswire] - Net cash used in operating and investing activities was $41.1 million in the fourth quarter and $133.9 million for the full year 2016; year-end cash and restricted cash position of $391 million supports ...
PRTA,PRTA:UW,BBG003PMQJT6,"The Zacks Analyst Blog Highlights: Incyte, Prothena, Acorda Therapeutics and Axovant Sciences",2017-02-14 16:21:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XArl_odGSIs/the-zacks-analyst-blog-highlights-incyte-prothena-acorda-therapeutics-and-axovant-sciences-cm747612,For Immediate Release Chicago IL February 14 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
PRTA,PRTA:UW,BBG003PMQJT6,"The Zacks Analyst Blog Highlights: Incyte, Prothena, Acorda Therapeutics and Axovant Sciences",2017-02-14 14:30:02 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-incyte-143002620.html,"The Zacks Analyst Blog Highlights: Incyte, Prothena, Acorda Therapeutics and Axovant Sciences"
PRTA,PRTA:UW,BBG003PMQJT6,"The Zacks Analyst Blog Highlights: Incyte, Prothena, Acorda Therapeutics and Axovant Sciences",2017-02-14 14:30:02 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-incyte-143002620.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: Incyte, Prothena, Acorda Therapeutics and Axovant Sciences"
PRTA,PRTA:UW,BBG003PMQJT6,Q4 2016 Prothena Corporation PLC Earnings Release - After Market Close,2017-02-14 12:07:02 +0000,http://biz.yahoo.com/research/earncal/20170214.html?t=prta,Q4 2016 Prothena Corporation PLC Earnings Release - After Market Close
PRTA,PRTA:UW,BBG003PMQJT6,"Drug Stocks Earnings Slated for Feb 14: INCY, PRTA & More",2017-02-13 14:19:02 +0000,http://finance.yahoo.com/news/drug-stocks-earnings-slated-feb-141902186.html,"Drug Stocks Earnings Slated for Feb 14: INCY, PRTA & More"
PRTA,PRTA:UW,BBG003PMQJT6,"Drug Stocks Earnings Slated for Feb 14: INCY, PRTA & More",2017-02-13 14:19:02 +0000,http://finance.yahoo.com/news/drug-stocks-earnings-slated-feb-141902186.html?.tsrc=rss,The year 2017 seems to have started on a positive note for investors in the U.S. Approximately 71.6% of the companies (or 358 members) in the S&P 500 Index have reported results so far.
PRTA,PRTA:UW,BBG003PMQJT6,Can Prothena (PRTA) Pull a Surprise This Earnings Season?,2017-02-08 23:16:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aaxUnIyFFdQ/can-prothena-prta-pull-a-surprise-this-earnings-season-cm745195,Prothena Corporation plc PRTA is scheduled to report fourth quarter 2016 results on Feb 14 after the market closes Prothena s share price has increased 61 7 in the past one year while the Zacks classified Medical Biomedical and Genetics industry declined 0 4 Last
PRTA,PRTA:UW,BBG003PMQJT6,Can Prothena (PRTA) Pull a Surprise This Earnings Season?,2017-02-08 21:16:09 +0000,http://finance.yahoo.com/news/prothena-prta-pull-surprise-earnings-211609623.html,Can Prothena (PRTA) Pull a Surprise This Earnings Season?
PRTA,PRTA:UW,BBG003PMQJT6,Prothena to Participate in the Leerink Partners 6th Annual Global Healthcare Conference,2017-02-08 21:06:02 +0000,http://finance.yahoo.com/news/prothena-participate-leerink-partners-6th-210602028.html,"[GlobeNewswire] - DUBLIN, Ireland, Feb. 08, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel ..."
PRTA,PRTA:UW,BBG003PMQJT6,Blog Coverage VBI Vaccines Receives Positive Scientific Advice from EMA's Committee for Medicinal Products for Human Use its 3rd Generation Hepatitis B Vaccine,2017-02-08 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-vbi-vaccines-receives-131500649.html,"[Accesswire] - Upcoming AWS Coverage on Prothena Post-Earnings Results LONDON, UK / ACCESSWIRE / February 8, 2017 / Active Wall St. blog coverage looks at the headline from VBI Vaccines, Inc. (NASDAQ: VBIV ) as the Company ..."
PRTA,PRTA:UW,BBG003PMQJT6,Prothena to Report Fourth Quarter and Full Year 2016 Financial Results and Host Webcast Conference Call on February 14,2017-02-01 21:07:02 +0000,http://finance.yahoo.com/news/prothena-report-fourth-quarter-full-210702068.html,"[GlobeNewswire] - DUBLIN, Ireland, Feb. 01, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel ..."
PRTA,PRTA:UW,BBG003PMQJT6,Prothena Grabbing At Chunk Of $201B Immunotherapy Market: CEO Exclusive,2017-01-20 21:27:40 +0000,http://www.investors.com/news/technology/prothena-grabbing-at-chunk-of-19-billion-i-o-market-ceo-exclusive/,Prothena Grabbing At Chunk Of $201B Immunotherapy Market: CEO Exclusive
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Corp. Plc – Value Analysis (NASDAQ:PRTA) : January 10, 2017",2017-01-10 16:05:51 +0000,http://www.capitalcube.com/blog/index.php/prothena-corp-plc-value-analysis-nasdaqprta-january-10-2017/,"Prothena Corp. Plc – Value Analysis (NASDAQ:PRTA) : January 10, 2017"
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Corp. Plc breached its 50 day moving average in a Bullish Manner : PRTA-US : January 9, 2017",2017-01-09 12:21:23 +0000,http://www.capitalcube.com/blog/index.php/prothena-corp-plc-breached-its-50-day-moving-average-in-a-bullish-manner-prta-us-january-9-2017/,"Prothena Corp. Plc breached its 50 day moving average in a Bullish Manner : PRTA-US : January 9, 2017"
PRTA,PRTA:UW,BBG003PMQJT6,Prothena to Participate in the J.P. Morgan Healthcare Conference,2017-01-04 21:06:02 +0000,http://finance.yahoo.com/news/prothena-participate-j-p-morgan-210602011.html,"[GlobeNewswire] - DUBLIN, Ireland, Jan. 04, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel ..."
PRTA,PRTA:UW,BBG003PMQJT6,"Commit To Purchase Prothena Corp At $35, Earn 15.1% Annualized Using Options",2016-12-27 17:57:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FRJQ0ZpA2mI/commit-to-purchase-prothena-corp-at-35-earn-151-annualized-using-options-cm726527,Investors considering a purchase of Prothena Corp plc Symbol PRTA stock but tentative about paying the going market price of 51 95 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is the
PRTA,PRTA:UW,BBG003PMQJT6,PRTA Crosses Below Key Moving Average Level,2016-12-22 17:58:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pYmCgmULCh4/prta-crosses-below-key-moving-average-level-cm725222,In trading on Thursday shares of Prothena Corp plc Symbol PRTA crossed below their 200 day moving average of 49 88 changing hands as low as 49 34 per share Prothena Corp plc shares are currently trading down about 1 1 on the day The chart below shows the one year performance of
PRTA,PRTA:UW,BBG003PMQJT6,Prothena Announces Appointment of Chief Regulatory Officer,2016-12-15 21:06:01 +0000,http://finance.yahoo.com/news/prothena-announces-appointment-chief-regulatory-210601576.html,"[GlobeNewswire] - DUBLIN, Ireland, Dec. 15, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel ..."
PRTA,PRTA:UW,BBG003PMQJT6,"First-In-Human Assessment of PRX002, Prothena's Anti-Alpha Synuclein Antibody for Parkinson's Disease, Published in Movement Disorders Journal",2016-12-13 21:06:02 +0000,http://finance.yahoo.com/news/first-human-assessment-prx002-prothenas-210602240.html,"[GlobeNewswire] - Data Previously Presented in 2015 at 19th International Congress of Parkinson`s Disease and Movement Disorders DUBLIN, Ireland, Dec. 13, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), ..."
PRTA,PRTA:UW,BBG003PMQJT6,"First-In-Human Assessment of PRX002, Prothena’s Anti-Alpha Synuclein Antibody for Parkinson’s Disease, Published in Movement Disorders Journal",2016-12-13 21:05:00 +0000,http://finance.yahoo.com/news/first-human-assessment-prx002-prothena-210500791.html,"[GlobeNewswire] - DUBLIN, Ireland, Dec. 13, 2016-- Prothena Corporation plc, a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapies, today ..."
PRTA,PRTA:UW,BBG003PMQJT6,Drug Stocks Topple On Donald Trump's Pledge To Bring Down Drug Prices,2016-12-07 21:12:13 +0000,http://www.investors.com/research/ibd-industry-themes/biotechs-topple-on-donald-trumps-pledge-to-bring-down-drug-prices/,Drug Stocks Topple On Donald Trump's Pledge To Bring Down Drug Prices
PRTA,PRTA:UW,BBG003PMQJT6,Anthera Announces Leadership Transition in Preparation of Commercialization of Sollpura and Future Development of blisibimod for IgA Nephropathy,2016-12-06 21:10:00 +0000,http://finance.yahoo.com/news/anthera-announces-leadership-transition-preparation-211000003.html,[GlobeNewswire] - J. Craig Thompson promoted to Chief Executive Officer and appointed to the Board of Directors Paul F. Truex appointed as Executive Chairman of the Board Dr. Christopher Henney stepped down as Chairman ...
PRTA,PRTA:UW,BBG003PMQJT6,Is Prothena Corporation PLC (PRTA) Going to Burn These Hedge Funds?,2016-12-05 07:08:37 +0000,http://www.insidermonkey.com/blog/is-prothena-corporation-plc-prta-going-to-burn-these-hedge-funds-498205/,Is Prothena Corporation PLC (PRTA) Going to Burn These Hedge Funds?
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Corp. Plc breached its 50 day moving average in a Bearish Manner : PRTA-US : December 2, 2016",2016-12-02 12:45:22 +0000,http://www.capitalcube.com/blog/index.php/prothena-corp-plc-breached-its-50-day-moving-average-in-a-bearish-manner-prta-us-december-2-2016/,"Prothena Corp. Plc breached its 50 day moving average in a Bearish Manner : PRTA-US : December 2, 2016"
PRTA,PRTA:UW,BBG003PMQJT6,"Celgene, Kite, Spark Look To Sidestep Lilly Alzheimer's Flop",2016-11-30 21:15:50 +0000,http://www.investors.com/news/technology/celgene-kite-spark-look-to-sidestep-lilly-alzheimers-flop-at-ash/,"Celgene, Kite, Spark Look To Sidestep Lilly Alzheimer's Flop"
PRTA,PRTA:UW,BBG003PMQJT6,"PROTHENA CORP PLC Files SEC form 8-K, Change in Directors or Principal Officers",2016-11-28 21:18:33 +0000,http://biz.yahoo.com/e/161128/prta8-k.html,"PROTHENA CORP PLC Files SEC form 8-K, Change in Directors or Principal Officers"
PRTA,PRTA:UW,BBG003PMQJT6,"ETFs with exposure to Prothena Corp. Plc : November 25, 2016",2016-11-25 15:24:04 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-prothena-corp-plc-november-25-2016/,"ETFs with exposure to Prothena Corp. Plc : November 25, 2016"
PRTA,PRTA:UW,BBG003PMQJT6,"ETFs with exposure to Prothena Corp. Plc : November 14, 2016",2016-11-14 19:14:20 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-prothena-corp-plc-november-14-2016/,"ETFs with exposure to Prothena Corp. Plc : November 14, 2016"
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Corp. Plc :PRTA-US: Earnings Analysis: Q3, 2016 By the Numbers : November 11, 2016",2016-11-11 15:57:43 +0000,http://www.capitalcube.com/blog/index.php/prothena-corp-plc-prta-us-earnings-analysis-q3-2016-by-the-numbers-november-11-2016/,"Prothena Corp. Plc :PRTA-US: Earnings Analysis: Q3, 2016 By the Numbers : November 11, 2016"
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Corp. Plc breached its 50 day moving average in a Bullish Manner : PRTA-US : November 11, 2016",2016-11-11 12:10:08 +0000,http://www.capitalcube.com/blog/index.php/prothena-corp-plc-breached-its-50-day-moving-average-in-a-bullish-manner-prta-us-november-11-2016/,"Prothena Corp. Plc breached its 50 day moving average in a Bullish Manner : PRTA-US : November 11, 2016"
PRTA,PRTA:UW,BBG003PMQJT6,Prothena Stock Outplays Broader Biotechs On Key Parkinson's Study,2016-11-10 21:41:51 +0000,http://www.investors.com/news/technology/prothena-stock-outplays-broader-biotechs-on-key-parkinsons-study/,Prothena Stock Outplays Broader Biotechs On Key Parkinson's Study
PRTA,PRTA:UW,BBG003PMQJT6,"AbbVie Inc (ABBV), Alkermes PLC (ALKS): Will Woodford Investment’s Long Positions Rule the Market Again in Q4?",2016-11-10 13:50:59 +0000,http://www.insidermonkey.com/blog/abbvie-inc-abbv-alkermes-plc-alks-will-woodford-investments-long-positions-rule-the-market-again-in-q4-485485/,"AbbVie Inc (ABBV), Alkermes PLC (ALKS): Will Woodford Investment’s Long Positions Rule the Market Again in Q4?"
PRTA,PRTA:UW,BBG003PMQJT6,"ADAP Surges As FDA Lifts Clinical Hold, OCUL Catches Eyes, RegeneRx On The Rise",2016-11-10 01:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dQSDgHm_C-g/adap-surges-as-fda-lifts-clinical-hold-ocul-catches-eyes-regenerx-on-the-rise-20161110-00064,"ADAP Surges As FDA Lifts Clinical Hold, OCUL Catches Eyes, RegeneRx On The Rise"
PRTA,PRTA:UW,BBG003PMQJT6,"Biotech, Drug Stocks Fly On Clinton Loss, But 'Trump Uncertainty'",2016-11-09 21:33:40 +0000,http://www.investors.com/research/ibd-industry-themes/biotechs-drugs-fly-on-clinton-defeat-but-trump-uncertainty-lingers/,"Biotech, Drug Stocks Fly On Clinton Loss, But 'Trump Uncertainty'"
PRTA,PRTA:UW,BBG003PMQJT6,"PROTHENA CORP PLC Files SEC form 8-K, Other Events",2016-11-09 21:21:01 +0000,http://biz.yahoo.com/e/161109/prta8-k.html,"PROTHENA CORP PLC Files SEC form 8-K, Other Events"
PRTA,PRTA:UW,BBG003PMQJT6,Prothena Reports Results from Phase 1b Study of PRX002 Demonstrating Robust Antibody CNS Penetration and Significant Reduction of Free Serum Alpha-synuclein in Patients with Parkinson's Disease,2016-11-09 21:11:10 +0000,http://www.publicnow.com/view/04C7D113CF2F51842E78C2F3FB6E18771046AA72,"[at noodls] - All dose levels of PRX002 found to have an acceptable safety and tolerability profile, meeting the primary objective of this study Robust central nervous system (CNS) penetration demonstrated by a dose-dependent ..."
PRTA,PRTA:UW,BBG003PMQJT6,Prothena Reports Results from Phase 1b Study of PRX002 Demonstrating Robust Antibody CNS Penetration and Significant Reduction of Free Serum Alpha-synuclein in Patients with Parkinson’s Disease,2016-11-09 21:05:00 +0000,http://finance.yahoo.com/news/prothena-reports-results-phase-1b-210500749.html,"[GlobeNewswire] - All dose levels of PRX002 found to have an acceptable safety and tolerability profile, meeting the primary objective of this study Robust central nervous system penetration demonstrated by a dose-dependent ..."
PRTA,PRTA:UW,BBG003PMQJT6,"PROTHENA CORP PLC Files SEC form 8-K/A, Change in Directors or Principal Officers, Financial Statements and Exhibits",2016-11-04 20:10:45 +0000,http://biz.yahoo.com/e/161104/prta8-k_a.html,"PROTHENA CORP PLC Files SEC form 8-K/A, Change in Directors or Principal Officers, Financial Statements and Exhibits"
PRTA,PRTA:UW,BBG003PMQJT6,Data for Prothena's NEOD001 to be Presented at the 58th Annual American Society of Hematology Meeting,2016-11-03 13:21:02 +0000,http://finance.yahoo.com/news/data-prothenas-neod001-presented-58th-132102952.html,"[GlobeNewswire] - Data for Prothena`s NEOD001 to be Presented at the 58th Annual American Society of Hematology Meeting DUBLIN, Ireland, Nov. 03, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage ..."
PRTA,PRTA:UW,BBG003PMQJT6,Data for Prothena’s NEOD001 to be Presented at the 58th Annual American Society of Hematology Meeting,2016-11-03 13:20:00 +0000,http://finance.yahoo.com/news/data-prothena-neod001-presented-58th-132000055.html,"[GlobeNewswire] - DUBLIN, Ireland, Nov. 03, 2016-- Prothena Corporation plc, a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapies, today ..."
PRTA,PRTA:UW,BBG003PMQJT6,Prothena (PRTA) Reports Wider-than-Expected Loss in Q3,2016-11-02 13:16:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3LfteEggr9c/prothena-prta-reports-wider-than-expected-loss-in-q3-cm702300,Prothena Corporation plc PRTA reported a loss of 1 26 per share in the third quarter of 2016 wider than both the Zacks Consensus Estimate of a loss of 1 23 and the year ago loss of 73 cents Moreover quarterly revenues came in at 0 3 million down 25 primarily due to
PRTA,PRTA:UW,BBG003PMQJT6,Prothena (PRTA) Reports Wider-than-Expected Loss in Q3,2016-11-02 12:14:12 +0000,http://finance.yahoo.com/news/prothena-prta-reports-wider-expected-121412371.html,Prothena (PRTA) Reports Wider-than-Expected Loss in Q3
PRTA,PRTA:UW,BBG003PMQJT6,"PROTHENA CORP PLC Files SEC form 10-Q, Quarterly Report",2016-11-02 10:08:21 +0000,http://biz.yahoo.com/e/161102/prta10-q.html,"PROTHENA CORP PLC Files SEC form 10-Q, Quarterly Report"
PRTA,PRTA:UW,BBG003PMQJT6,"PTN Surges On Trial Data, PFE Dumps Cholesterol Drug, Watch Out For PRTA",2016-11-02 04:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z38L-536a5M/ptn-surges-on-trial-data-pfe-dumps-cholesterol-drug-watch-out-for-prta-20161102-00006,"PTN Surges On Trial Data, PFE Dumps Cholesterol Drug, Watch Out For PRTA"
PRTA,PRTA:UW,BBG003PMQJT6,Prothena reports 3Q loss,2016-11-01 21:40:13 +0000,http://sg.finance.yahoo.com/news/prothena-reports-3q-loss-214013901.html,Prothena reports 3Q loss
PRTA,PRTA:UW,BBG003PMQJT6,Prothena Reports Third Quarter 2016 Financial Results and Provides R&D Update,2016-11-01 20:16:07 +0000,http://www.publicnow.com/view/45E682C332F38A0246601D8143AF48966C77BC8F,[at noodls] - Net cash used in operating and investing activities was $39.1 million in the third quarter and $96.8 million for the first nine months of 2016; quarter-end cash and restricted cash position of $412.6 million ...
PRTA,PRTA:UW,BBG003PMQJT6,"PROTHENA CORP PLC Files SEC form 8-K, Results of Operations and Financial Condition",2016-11-01 20:12:23 +0000,http://biz.yahoo.com/e/161101/prta8-k.html,"PROTHENA CORP PLC Files SEC form 8-K, Results of Operations and Financial Condition"
PRTA,PRTA:UW,BBG003PMQJT6,Q3 2016 Prothena Corporation PLC Earnings Release - After Market Close,2016-11-01 11:07:04 +0000,http://biz.yahoo.com/research/earncal/20161101.html?t=prta,Q3 2016 Prothena Corporation PLC Earnings Release - After Market Close
PRTA,PRTA:UW,BBG003PMQJT6,Can Prothena (PRTA) Pull a Surprise This Earnings Season?,2016-10-26 14:53:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VI5LNRq9BeA/can-prothena-prta-pull-a-surprise-this-earnings-season-cm698575,Prothena Corporation plc PRTA is scheduled to report third quarter 2016 results on Nov 1 after the market closes Last reported quarter the company recorded a negative earnings surprise of 32 58 Let s see how things are shaping up for this announcement Factors at
PRTA,PRTA:UW,BBG003PMQJT6,Can Prothena (PRTA) Pull a Surprise This Earnings Season?,2016-10-26 13:16:01 +0000,http://finance.yahoo.com/news/prothena-prta-pull-surprise-earnings-131601368.html,Can Prothena (PRTA) Pull a Surprise This Earnings Season?
PRTA,PRTA:UW,BBG003PMQJT6,Prothena to Report Third Quarter 2016 Financial Results on November 1,2016-10-25 20:15:07 +0000,http://www.publicnow.com/view/0F9CB08807867300543B27C4CE8EF9F614956506,"[at noodls] - DUBLIN, Ireland, Oct. 25, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel ..."
PRTA,PRTA:UW,BBG003PMQJT6,Can These Top 5 Biotechs Climb Q3 'Wall Of Worry'? RBC Calls For Rally,2016-10-13 20:37:53 +0000,http://www.investors.com/news/technology/can-these-top-5-biotechs-climb-q3-wall-of-worry-rbc-calls-for-rally/,Can These Top 5 Biotechs Climb Q3 'Wall Of Worry'? RBC Calls For Rally
PRTA,PRTA:UW,BBG003PMQJT6,Prothena Slammed On Politics; Could Win Eli Lilly Or Pfizer Partnership,2016-10-13 20:09:21 +0000,http://www.investors.com/news/technology/prothena-slammed-on-politics-could-win-eli-lilly-or-pfizer-partnership/,Prothena Slammed On Politics; Could Win Eli Lilly Or Pfizer Partnership
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Corp. Plc breached its 50 day moving average in a Bearish Manner : PRTA-US : October 13, 2016",2016-10-13 12:27:39 +0000,http://www.capitalcube.com/blog/index.php/prothena-corp-plc-breached-its-50-day-moving-average-in-a-bearish-manner-prta-us-october-13-2016/,"Prothena Corp. Plc breached its 50 day moving average in a Bearish Manner : PRTA-US : October 13, 2016"
PRTA,PRTA:UW,BBG003PMQJT6,"Biotechs Worst-Performing Stocks Wednesday; Prothena, Supernus Fall",2016-10-12 20:22:01 +0000,http://www.investors.com/news/technology/biotechs-worst-performing-stocks-wednesday-prothena-supernus-fall/,"Biotechs Worst-Performing Stocks Wednesday; Prothena, Supernus Fall"
PRTA,PRTA:UW,BBG003PMQJT6,"PROTHENA CORP PLC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits",2016-10-03 13:24:30 +0000,http://biz.yahoo.com/e/161003/prta8-k.html,"PROTHENA CORP PLC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits"
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Announces Appointment of Dr. Gene G. Kinney as President, Chief Executive Officer and Director",2016-10-03 11:06:02 +0000,http://www.publicnow.com/view/34FA8D5690763B094E21551A8F1E4C5C80D89A13,"[at noodls] - DUBLIN, Ireland, Oct. 03, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel ..."
PRTA,PRTA:UW,BBG003PMQJT6,"Dale B. Schenk, Prothena Corp. Co-Founder and CEO, Dies at 59",2016-09-30 23:04:31 +0000,http://www.bloomberg.com/news/articles/2016-09-30/dale-b-schenk-prothena-corp-co-founder-and-ceo-dies-at-59?cmpid=yhoo.headline,"Dale B. Schenk, Prothena Corp. Co-Founder and CEO, Dies at 59"
PRTA,PRTA:UW,BBG003PMQJT6,Prothena Builds On Psoriasis Science For Arthritis Treatment,2016-09-30 20:54:31 +0000,http://www.investors.com/news/technology/prothena-builds-on-psoriasis-science-for-arthritis-treatment/,Prothena Builds On Psoriasis Science For Arthritis Treatment
PRTA,PRTA:UW,BBG003PMQJT6,"In Memoriam - Friend, Scientific Innovator and Leader Dr. Dale B. Schenk has Passed Away",2016-09-30 18:51:01 +0000,http://finance.yahoo.com/news/memoriam-friend-scientific-innovator-leader-185101931.html,"[GlobeNewswire] - DUBLIN, Ireland, Sept. 30, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), announced today that its Co-founder, President and Chief Executive Officer, Dr. Dale B. Schenk, passed away ..."
PRTA,PRTA:UW,BBG003PMQJT6,"In Memoriam – Friend, Scientific Innovator and Leader Dr. Dale B. Schenk has Passed Away",2016-09-30 18:45:00 +0000,http://finance.yahoo.com/news/memoriam-friend-scientific-innovator-leader-184500423.html,"[GlobeNewswire] - DUBLIN, Ireland, Sept. 30, 2016-- Prothena Corporation plc, announced today that its Co-founder, President and Chief Executive Officer, Dr. Dale B. Schenk, passed away this morning, after confronting his ..."
PRTA,PRTA:UW,BBG003PMQJT6,Prothena Outlines Phase 2 Development Strategy for PRX003,2016-09-29 20:20:05 +0000,http://www.publicnow.com/view/26F9433D5C5EA15B62F99FFDA1443601CAC23B9B,"[at noodls] - Investor conference call and webcast planned today at 4:30 PM ET DUBLIN, Ireland, Sept. 29, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company ..."
PRTA,PRTA:UW,BBG003PMQJT6,"PROTHENA CORP PLC Files SEC form 8-K, Change in Directors or Principal Officers",2016-09-26 20:13:13 +0000,http://biz.yahoo.com/e/160926/prta8-k.html,"PROTHENA CORP PLC Files SEC form 8-K, Change in Directors or Principal Officers"
PRTA,PRTA:UW,BBG003PMQJT6,Prothena Announces President and CEO Dr. Dale B. Schenk to Take Medical Leave,2016-09-26 20:09:06 +0000,http://www.publicnow.com/view/B572DCD31FD2AFF7B1F2335FBEF9443433E43C03,"[at noodls] - DUBLIN, Ireland, Sept. 26, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development, and commercialization of novel ..."
PRTA,PRTA:UW,BBG003PMQJT6,Prothena to Host Update on PRX003 Phase 2 Development Strategy,2016-09-22 20:11:07 +0000,http://www.publicnow.com/view/9F8981CE1023E57F3C75C3267DA13E6A3AC915AC,"[at noodls] - DUBLIN, Ireland, Sept. 22, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development, and commercialization of novel ..."
PRTA,PRTA:UW,BBG003PMQJT6,"ETF’s with exposure to Prothena Corp. Plc : September 16, 2016",2016-09-16 15:21:30 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-prothena-corp-plc-september-16-2016/,"ETF’s with exposure to Prothena Corp. Plc : September 16, 2016"
PRTA,PRTA:UW,BBG003PMQJT6,"PROTHENA CORP PLC Files SEC form 8-K, Change in Directors or Principal Officers",2016-09-06 20:27:49 +0000,http://biz.yahoo.com/e/160906/prta8-k.html,"PROTHENA CORP PLC Files SEC form 8-K, Change in Directors or Principal Officers"
PRTA,PRTA:UW,BBG003PMQJT6,Prothena Announces Appointment of Gene G. Kinney as Chief Operating Officer,2016-09-06 20:09:01 +0000,http://www.publicnow.com/view/9F28C811B9A0955F771973DA1331755706CCF435,"[at noodls] - DUBLIN, Ireland, Sept. 06, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development, and commercialization of novel ..."
PRTA,PRTA:UW,BBG003PMQJT6,"ETF’s with exposure to Prothena Corp. Plc : August 31, 2016",2016-08-31 15:45:35 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-prothena-corp-plc-august-31-2016/,"ETF’s with exposure to Prothena Corp. Plc : August 31, 2016"
PRTA,PRTA:UW,BBG003PMQJT6,Prothena to Participate in Upcoming September Investor Conferences,2016-08-30 20:06:02 +0000,http://finance.yahoo.com/news/prothena-participate-upcoming-september-investor-200602174.html,"[GlobeNewswire] - DUBLIN, Ireland, Aug. 30, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development, and commercialization of novel ..."
PRTA,PRTA:UW,BBG003PMQJT6,"ETF’s with exposure to Prothena Corp. Plc : August 9, 2016",2016-08-09 18:01:01 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-prothena-corp-plc-august-9-2016/,"ETF’s with exposure to Prothena Corp. Plc : August 9, 2016"
PRTA,PRTA:UW,BBG003PMQJT6,Why Prothena Corp plc Skyrocketed 43% in July,2016-08-07 04:16:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x0oGSrP4_PQ/why-prothena-corp-plc-skyrocketed-43-in-july-cm661475,"Image source  Getty Images.  What  Ahead of second quarter financial results and key trial data for its Parkinson's disease drug, shares in Prothena Corp. plc (NASDAQ  PRTA) soared 43.2% in July, according"
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Corp. Plc :PRTA-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016",2016-08-05 14:17:49 +0000,http://www.capitalcube.com/blog/index.php/prothena-corp-plc-prta-us-earnings-analysis-q2-2016-by-the-numbers-august-5-2016/,"Prothena Corp. Plc :PRTA-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016"
PRTA,PRTA:UW,BBG003PMQJT6,Here’s A Look At Prothena Corporation PLC (PRTA)’s Upcoming Milestones,2016-08-03 18:36:54 +0000,http://www.insidermonkey.com/blog/heres-a-look-at-prothena-corporation-plc-prtas-upcoming-milestones-467571/,Here’s A Look At Prothena Corporation PLC (PRTA)’s Upcoming Milestones
PRTA,PRTA:UW,BBG003PMQJT6,Prothena (PRTA) Reports Wider-than-Anticipated Loss in Q2,2016-08-03 16:59:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e6YefuOoXEw/prothena-prta-reports-wider-than-anticipated-loss-in-q2-cm659765,"Prothena Corporation plcPRTA reported a loss of $1.18 per share in the second quarter of 2016, much wider than both the Zacks Consensus Estimate of a loss of 89 cents and the year ago loss of 59 cents. Quarterly"
PRTA,PRTA:UW,BBG003PMQJT6,Prothena (PRTA) Reports Wider-than-Anticipated Loss in Q2,2016-08-03 14:45:02 +0000,http://finance.yahoo.com/news/prothena-prta-reports-wider-anticipated-144502103.html,Prothena (PRTA) Reports Wider-than-Anticipated Loss in Q2
PRTA,PRTA:UW,BBG003PMQJT6,Prothena reports 2Q loss,2016-08-02 22:23:26 +0000,http://sg.finance.yahoo.com/news/prothena-reports-2q-loss-222326682.html,Prothena reports 2Q loss
PRTA,PRTA:UW,BBG003PMQJT6,"PROTHENA CORP PLC Files SEC form 8-K, Results of Operations and Financial Condition",2016-08-02 20:11:43 +0000,http://biz.yahoo.com/e/160802/prta8-k.html,"PROTHENA CORP PLC Files SEC form 8-K, Results of Operations and Financial Condition"
PRTA,PRTA:UW,BBG003PMQJT6,Prothena Reports Second Quarter 2016 Financial Results; Provides R&D Update,2016-08-02 20:11:05 +0000,http://www.publicnow.com/view/8C795A19FEA4DB0CA19CFE7A535C32370A106B11,[at noodls] - Net cash used in operating and investing activities was $32.3 million in the second quarter and $57.7 million for the first six months of 2016; strong quarter-end cash and restricted cash position of $447.0 ...
PRTA,PRTA:UW,BBG003PMQJT6,What Awaits MNK & Other Drug Stocks this Earnings Season?,2016-08-01 14:00:02 +0000,http://finance.yahoo.com/news/awaits-mnk-other-drug-stocks-140002479.html,What Awaits MNK & Other Drug Stocks this Earnings Season?
PRTA,PRTA:UW,BBG003PMQJT6,What's in Store for Prothena (PRTA) This Earnings Season?,2016-07-29 22:25:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6Eq9TgzTCZs/whats-in-store-for-prothena-prta-this-earnings-season-cm657587,"Prothena Corporation plcPRTA is expected to report second quarter 2016 results on Aug 2. Prothena's track record has been has dismal so far. Over the four trailing quarters, the company's earnings have missed estimates thrice and beat the same"
PRTA,PRTA:UW,BBG003PMQJT6,What's in Store for Prothena (PRTA) This Earnings Season?,2016-07-29 20:44:08 +0000,http://finance.yahoo.com/news/whats-store-prothena-prta-earnings-204408051.html,What's in Store for Prothena (PRTA) This Earnings Season?
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Corp. Plc – Value Analysis (NASDAQ:PRTA) : July 18, 2016",2016-07-18 20:12:04 +0000,http://www.capitalcube.com/blog/index.php/prothena-corp-plc-value-analysis-nasdaqprta-july-18-2016/,"Prothena Corp. Plc – Value Analysis (NASDAQ:PRTA) : July 18, 2016"
PRTA,PRTA:UW,BBG003PMQJT6,"PROTHENA CORP PLC Files SEC form 8-K, Termination of a Material Definitive Agreement",2016-07-12 21:31:58 +0000,http://biz.yahoo.com/e/160712/prta8-k.html,"PROTHENA CORP PLC Files SEC form 8-K, Termination of a Material Definitive Agreement"
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Corp. Plc breached its 50 day moving average in a Bullish Manner : PRTA-US : July 11, 2016",2016-07-11 13:05:03 +0000,http://www.capitalcube.com/blog/index.php/prothena-corp-plc-breached-its-50-day-moving-average-in-a-bullish-manner-prta-us-july-11-2016/,"Prothena Corp. Plc breached its 50 day moving average in a Bullish Manner : PRTA-US : July 11, 2016"
PRTA,PRTA:UW,BBG003PMQJT6,"PROTHENA CORP PLC Files SEC form 8-K/A, Submission of Matters to a Vote of Security Holders",2016-07-08 20:24:30 +0000,http://biz.yahoo.com/e/160708/prta8-k_a.html,"PROTHENA CORP PLC Files SEC form 8-K/A, Submission of Matters to a Vote of Security Holders"
PRTA,PRTA:UW,BBG003PMQJT6,Prothena to Participate in Cantor Fitzgerald's 2nd Annual Healthcare Conference,2016-07-06 20:11:06 +0000,http://www.publicnow.com/view/5A4888F1712F61A03AED2E9E36EFA4B439B974A8,"[at noodls] - DUBLIN, Ireland, July 06, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel ..."
PRTA,PRTA:UW,BBG003PMQJT6,Prothena to Participate in Cantor Fitzgerald’s 2nd Annual Healthcare Conference,2016-07-06 20:05:00 +0000,http://finance.yahoo.com/news/prothena-participate-cantor-fitzgerald-2nd-200500773.html,"[GlobeNewswire] - DUBLIN, Ireland, July 06, 2016-- Prothena Corporation plc, a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapies, today ..."
PRTA,PRTA:UW,BBG003PMQJT6,Prothena Corporation PLC (PRTA)’s Amyloidosis Pipeline In Focus,2016-07-06 17:09:58 +0000,http://www.insidermonkey.com/blog/prothena-corporation-plc-prtas-amyloidosis-pipeline-in-focus-463221/,Prothena Corporation PLC (PRTA)’s Amyloidosis Pipeline In Focus
PRTA,PRTA:UW,BBG003PMQJT6,"PROTHENA CORP PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2016-07-05 11:34:31 +0000,http://biz.yahoo.com/e/160705/prta8-k.html,"PROTHENA CORP PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
PRTA,PRTA:UW,BBG003PMQJT6,Prothena Presents New Data from Phase 1/2 Study of NEOD001 Demonstrating Improvements in Three Organ Systems in Previously-Treated Patients with AL Amyloidosis,2016-07-05 11:11:04 +0000,http://www.publicnow.com/view/97BAB7A73A2D32BE66F5495E86B42E3185C16224,"[at noodls] - New data from Phase 1/2 dose-escalation (n=27) and expansion (n=42) study show best response rates in total cardiac- and renal- evaluable patients of 53% and 63%, respectively, that are consistent with ..."
PRTA,PRTA:UW,BBG003PMQJT6,3 Biotech Stocks at Risk From the 2016 U.S. Presidential Election (ANIP ARIA PRTA),2016-06-24 02:01:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nGZXv5ggWxI/3-biotech-stocks-at-risk-from-the-2016-us-presidential-election-anip-aria-prta-cm639932,"Depending on the outcome of the 2016 U.S. presidential election, biotech stocks could be the next great short play. And savvy investors seem to know which candidate has plans to"
PRTA,PRTA:UW,BBG003PMQJT6,Prothena to Present at 15th International Symposium on Amyloidosis Showcasing Broad Commitment to Advancing New Therapies for Systemic Amyloidoses,2016-06-21 20:19:02 +0000,http://www.publicnow.com/view/B9D5224AAD119902AEAFCA123B22248329C62F6E,"[at noodls] - New clinical data to be presented from Phase 1/2 dose-escalation and expansion trial of NEOD001 for the potential treatment of AL amyloidosis Presentations to highlight data from clinical, preclinical ..."
PRTA,PRTA:UW,BBG003PMQJT6,Prothena to Present at 15th International Symposium on Amyloidosis Showcasing Broad Commitment to...,2016-06-21 20:07:01 +0000,http://finance.yahoo.com/news/prothena-present-15th-international-symposium-200701679.html,[GlobeNewswire] - Prothena to Present at 15th International Symposium on Amyloidosis Showcasing Broad Commitment to Advancing New Therapies for Systemic Amyloidoses New clinical data to be presented from Phase 1/2 dose-escalation ...
PRTA,PRTA:UW,BBG003PMQJT6,First Week of PRTA August 19th Options Trading,2016-06-21 15:57:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XUI5HlFVRYM/first-week-of-prta-august-19th-options-trading-cm638425,"Investors in Prothena Corp plc (Symbol PRTA) saw new options become available this week, for the August 19th expiration. At Stock Options Channel , our YieldBoost formula has looked up and down the PRTA options chain for the new"
PRTA,PRTA:UW,BBG003PMQJT6,"MRK Opens Wallet, VRX To Face FDA Panel In July, SPHS Vaults On Trial Data",2016-06-09 22:37:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/79GGEf2nGOQ/mrk-opens-wallet-vrx-to-face-fda-panel-in-july-sphs-vaults-on-trial-data-20160609-01081,"MRK Opens Wallet, VRX To Face FDA Panel In July, SPHS Vaults On Trial Data"
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Reports Results of Phase 1 Single Ascending Dose Study of PRX003, Demonstrating Target Engagement of the Novel Anti-MCAM Antibody for Inflammatory Diseases",2016-06-09 20:09:04 +0000,http://www.publicnow.com/view/D2315DFE95B8F9F3A08275E29D75E6B1286CF695,"[at noodls] - All doses of PRX003 found to be safe and well tolerated, meeting the primary objective of the Phase 1 single ascending dose study in healthy volunteers Neutralization of Th17 cells of greater than 95 percent ..."
PRTA,PRTA:UW,BBG003PMQJT6,PRTA Crosses Above Key Moving Average Level,2016-06-02 16:53:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QzYcAbyHIvo/prta-crosses-above-key-moving-average-level-cm629571,"In trading on Thursday, shares of Prothena Corp plc (Symbol PRTA) crossed above their 200 day moving average of $49.79, changing hands as high as $50.41 per share. Prothena Corp plc shares are currently trading up about 4.4% on"
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena to Present Wide Range of Studies on Amyloidosis, Including New Clinical Data on NEOD001, at International Symposium on Amyloidosis",2016-05-23 20:16:08 +0000,http://www.publicnow.com/view/0793BE815A1CBC50A0D40A4CCE0346DC3D4C0AE7,[at noodls] - New clinical data to be presented from expansion cohort of Phase 1/2 trial of NEOD001 for the potential treatment of AL amyloidosis Additional presentations to highlight data from preclinical and quality ...
PRTA,PRTA:UW,BBG003PMQJT6,Prothena to Present Quality of Life Data on AL Amyloidosis at European Hematology Association 21st Congress,2016-05-19 20:52:06 +0000,http://www.publicnow.com/view/10EFB7F92177F6E3DA05506BDCB6423019847F90,"[at noodls] - DUBLIN, Ireland, May 19, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel ..."
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena to Present Clinical Results From its Phase 1 Single Ascending Dose Study of PRX003, an Anti-MCAM Antibody Being Investigated for Inflammatory Diseases, at EULAR 2016",2016-05-09 20:08:04 +0000,http://www.publicnow.com/view/34AC8FA4053B50A6EC94ED03F1162D01DDCAD2A1,"[at noodls] - DUBLIN, Ireland, May 09, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel ..."
PRTA,PRTA:UW,BBG003PMQJT6,Prothena (PRTA) Reports Wider-than-Expected Loss in Q1,2016-05-04 18:45:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_Wr4c4Ei9U8/prothena-prta-reports-wider-than-expected-loss-in-q1-cm616305,"Prothena Corporation plcPRTA reported a loss of 81 cents per share in the first quarter of 2016, much wider than both the Zacks Consensus Estimate of a loss of 70 cents and the year ago loss of 55 cents."
PRTA,PRTA:UW,BBG003PMQJT6,Prothena Reports First Quarter 2016 Financial Results and Provides R&D Update,2016-05-03 20:10:03 +0000,http://www.publicnow.com/view/AAC397C0A5D21A73F763FA209C218F6C2B6B8CE0,"[at noodls] - Net cash used in operating and investing activities was $25.4 million in the first quarter; strong quarter-end cash position of $474.3 million, including net proceeds of $128.6 million raised through January ..."
PRTA,PRTA:UW,BBG003PMQJT6,Prothena (PRTA): What's Ahead for the Stock in Q1 Earnings?,2016-04-28 01:08:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EXN0_0p9NTo/prothena-prta-whats-ahead-for-the-stock-in-q1-earnings-cm612790,"Prothena Corporation plcPRTA is expected to report first quarter 2016 results on May 3. Prothena's track record has been has mixed so far. Over the last four trailing quarters, the company's earnings missed estimates in the two quarters and"
PRTA,PRTA:UW,BBG003PMQJT6,3 Best Stocks for Risk-Tolerant Investors,2016-02-28 15:33:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dsxTxc2Si44/3-best-stocks-for-risk-tolerant-investors-cm585839,"Image by Alexas Fotos via pixabay.  Fools like us look for companies that are on rock solid financial footing, but we certainly believe that it can be a smart idea to invest"
PRTA,PRTA:UW,BBG003PMQJT6,Prothena (PRTA) Shows Strength: Stock Moves Up 8.9%,2016-02-22 15:29:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/atjH-xfwv7Y/prothena-prta-shows-strength-stock-moves-up-89-cm582765,"Prothena Corporation plcPRTA was a big mover last session, as the company saw its shares rise almost 9% on the day. The stock rallied on narrower than expected fourth quarter 20Array5 loss. This also led to far more shares"
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Q4 Loss Narrower than Expected, Pipeline in Focus",2016-02-19 18:49:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aeFa-3eQ-Cg/prothena-q4-loss-narrower-than-expected-pipeline-in-focus-cm582216,"Prothena Corporation plcPRTA reported a loss of 76 cents per share in the fourth quarter of 20Array5, narrower than the Zacks Consensus Estimate of a loss of 79 cents, but wider than the year ago loss of 48 cents."
PRTA,PRTA:UW,BBG003PMQJT6,Prothena reports 4Q loss,2016-02-18 22:27:43 +0000,http://sg.finance.yahoo.com/news/prothena-reports-4q-loss-222743610.html,Prothena reports 4Q loss
PRTA,PRTA:UW,BBG003PMQJT6,What's in Store for Prothena (PRTA) this Earnings Season?,2016-02-17 22:48:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/462RhqGem9o/whats-in-store-for-prothena-prta-this-earnings-season-cm581214,"Prothena CorporationPRTA is expected to report fourth quarter 2015 results on Feb 18, 2016. Over the last four trailing quarters, the company has posted an average positive earnings surprise of 4.70%. Prothena has a mixed track record, with the"
PRTA,PRTA:UW,BBG003PMQJT6,"Wednesday's ETF Movers: XBI, NANR",2016-02-10 20:11:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/44UfOWpE18k/wednesdays-etf-movers-xbi-nanr-cm578009,"In trading on Wednesday, the SPDR S&P Biotech ETF ( XBI ) is outperforming other ETFs, up about 3.6% on the day. Components of that ETF showing particular strength include shares of Spark Therapeutics ( ONCE ), up about"
PRTA,PRTA:UW,BBG003PMQJT6,Forget Gilead Sciences: These Stocks Doubled Last Year,2016-02-03 21:19:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7865IkhF6E4/forget-gilead-sciences-these-stocks-doubled-last-year-cm574465,"Image source  Gilead Sciences.  Gilead Sciences  has been a dream stock for long term investors. The stock has gained more than 4,930% since the turn of the millennium, turning the company"
PRTA,PRTA:UW,BBG003PMQJT6,Prothena to Participate in BIO CEO & Investor and Leerink Partners Healthcare Conferences,2016-02-01 21:12:50 +0000,http://www.publicnow.com/view/12E74AB526EB67C89B203D637611C16AF49AC728,"[at noodls] - DUBLIN, Ireland, Feb. 01, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel ..."
PRTA,PRTA:UW,BBG003PMQJT6,Prothena (PRTA) Looks Good: Stock Jumps 5.1% in Session,2016-02-01 15:19:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BX3WHMm9xKE/prothena-prta-looks-good-stock-jumps-51-in-session-cm572767,"Prothena Corporation plcPRTA was a big mover last session, as the company saw its shares rise over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session."
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena Announces Pricing of Public Offering of 2,250,000 Ordinary Shares",2016-01-07 13:12:27 +0000,http://www.noodls.com/view/9F75DBDD9DCB8B925732F8E0CC712192BC468F87,"[at noodls] - DUBLIN, Ireland, Jan. 07, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel ..."
PRTA,PRTA:UW,BBG003PMQJT6,Prothena Announces Proposed Offering of Ordinary Shares,2016-01-05 21:10:06 +0000,http://www.noodls.com/view/23B8B3619C63D4EFFD2528B52756AFFC4E4E62E0,"[at noodls] - DUBLIN, Ireland, Jan. 05, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel ..."
PRTA,PRTA:UW,BBG003PMQJT6,Prothena to Participate in Oppenheimer and RBC Capital Markets Healthcare Investor Conferences,2015-12-01 21:15:29 +0000,http://www.noodls.com/view/86A23667F9A455E73A42616E105CD753BCF97D8C,[at noodls] - Prothena to Participate in Oppenheimer and RBC Capital Markets Healthcare Investor Conferences
PRTA,PRTA:UW,BBG003PMQJT6,Prothena to Present New Preclinical Data for NEOD001 at 57th Annual American Society of Hematology Meeting,2015-11-05 14:30:10 +0000,http://www.noodls.com/view/1B9468B130A97C5651115673C97E5C2030D2734B,[at noodls] - Prothena to Present New Preclinical Data for NEOD001 at 57th Annual American Society of Hematology Meeting
PRTA,PRTA:UW,BBG003PMQJT6,Prothena Reports Third Quarter 2015 Financial Results and Provides R&D Update,2015-11-02 21:16:20 +0000,http://www.noodls.com/view/33BB631E6C7973F99DC255B6A0A4DE4416FC49C8,[at noodls] - Net cash used in operating activities was $16.9 million in the third quarter and $42.8 million for first nine months of 2015; quarter-end cash position of $387.8 million provides solid runway for continued ...
PRTA,PRTA:UW,BBG003PMQJT6,"Prothena to Initiate PRONTO, a Global Trial of NEOD001 in Patients With AL Amyloidosis With Primary Endpoint of Cardiac Response",2015-10-15 20:12:13 +0000,http://www.noodls.com/view/BC477B6424809BAC1E3F2D9D8EEC508CBE600912,"[at noodls] - Accelerates Development Timeline and Potential Path to Patients Prothena to Host Investor Conference Call and Webcast Today at 4:30 p.m. ET DUBLIN, Ireland, Oct. 15, 2015 (GLOBE NEWSWIRE) -- Prothena Corporation ..."
PRTA,PRTA:UW,BBG003PMQJT6,Prothena to Present at Ladenburg Thalmann 2015 Healthcare Conference on September 29,2015-09-22 20:15:12 +0000,http://www.noodls.com/view/2208186D66F108821ABD7E7EF572A6530F79AC18,"[at noodls] - DUBLIN, Ireland, Sept. 22, 2015 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel ..."
PRTA,PRTA:UW,BBG003PMQJT6,Prothena reports 1Q loss,2015-05-05 21:21:59 +0000,http://sg.finance.yahoo.com/news/prothena-reports-1q-loss-212159357.html,Prothena reports 1Q loss
PRTA,PRTA:UW,BBG003PMQJT6,Prothena posts 3Q loss,2014-11-03 23:39:49 +0000,http://sg.finance.yahoo.com/news/prothena-posts-3q-loss-233949002--finance.html,Prothena posts 3Q loss
